The session, “Implement Advanced Monitoring Strategies and Leverage Data to Provide Business Value,” will focus on how to gain actionable insights from the data available to compliance officers for transparency reporting.
| PORTSMOUTH, N.H., Feb. 21, 2019 /PRNewswire/ -- Darryl Williams, senior director of analytics at MediSpend, will discuss how to utilize data and maximize advanced monitoring strategies to improve business results in the life sciences industry at the 7th Annual CBI Compliance Monitoring Congress at 3:50 pm on Wednesday, February 27, 2019 in Philadelphia, PA. The session, “Implement Advanced Monitoring Strategies and Leverage Data to Provide Business Value,” will focus on how to gain actionable insights from the data available to compliance officers for transparency reporting.
“Real time, or near time, monitoring of enterprise data amplifies high risk areas throughout the organization,” said Williams. “The ability to identify outliers and drill down into non-compliant activities enhances the effectiveness of strategic decision making throughout the organization.” The CBI conference is a chance for leading life sciences experts to cover the challenges of managing expanding compliance monitoring efforts to mitigate risk. Participants will explore ways to further develop their own compliance monitoring strategies. They will discuss how to put together the optimal compliance team, explore tools and processes to automate transparency reporting and deploy effective strategies to manage anti-bribery and anti-corruption risks associated with third-party vendors. About MediSpend Media Contact:
SOURCE MediSpend |
View original content to download multimedia:
